SummaryAccumulation of toxic metabolites in hereditary tyrosinemia type I (HT1) patients leads to chronic DNA damage and the highest risk for hepatocellular carcinomas (HCCs) of any human disease. Here we show that hepatocytes of HT1 mice exhibit a profound cell-cycle arrest that, despite concomitant apoptosis resistance, causes mortality from impaired liver regeneration. However, additional loss of p21 in HT1 mice restores the proliferative capabilities of hepatocytes and renal proximal tubular cells. This growth response compensates cell loss due to uninhibited apoptosis and enables animal survival but rapidly leads to HCCs, renal cysts, and renal carcinomas. Thus, p21's antiproliferative function is indispensable for the suppression of c...
The CDK inhibitor p21 (WAF-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G1 ...
Hereditary Tyrosinemia type 1 (HT1) is a metabolic liver disease caused by genetic defects of fumary...
Genetic mouse studies suggest that the NF-¿B pathway regulator NEMO (also known as IKK¿) controls ch...
Hepatocellular carcinoma (HCC) frequently arises in the context of chronic injury that promotes DNA ...
BACKGROUND AND AIMS: A coordinated stress and regenerative response is important following hepatocyt...
Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure.Backg...
Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure.Backg...
AbstractHereditary tyrosinemia type 1 (HT1) is the most severe inherited metabolic disease of the ty...
Regulation of hepatocellular apoptosis is crucial for liver homeostasis. Increased sensitivity of he...
Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosi...
Overexpression of p21 in NEMOΔhepa animals protects against DNA damage, acceleration of hepatocarcin...
The CDK inhibitor p21 (WAF-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G1 ...
Overexpression of p21 in NEMOΔhepa animals protects against DNA damage, acceleration of hepatocarcin...
Despite good evidence for p53 dysfunction in human hepatocellular carcinomas, little is known of the...
Every year 500 000 people die worldwide due to the consequences of a hepatocellular carcinoma (HCC)....
The CDK inhibitor p21 (WAF-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G1 ...
Hereditary Tyrosinemia type 1 (HT1) is a metabolic liver disease caused by genetic defects of fumary...
Genetic mouse studies suggest that the NF-¿B pathway regulator NEMO (also known as IKK¿) controls ch...
Hepatocellular carcinoma (HCC) frequently arises in the context of chronic injury that promotes DNA ...
BACKGROUND AND AIMS: A coordinated stress and regenerative response is important following hepatocyt...
Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure.Backg...
Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure.Backg...
AbstractHereditary tyrosinemia type 1 (HT1) is the most severe inherited metabolic disease of the ty...
Regulation of hepatocellular apoptosis is crucial for liver homeostasis. Increased sensitivity of he...
Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosi...
Overexpression of p21 in NEMOΔhepa animals protects against DNA damage, acceleration of hepatocarcin...
The CDK inhibitor p21 (WAF-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G1 ...
Overexpression of p21 in NEMOΔhepa animals protects against DNA damage, acceleration of hepatocarcin...
Despite good evidence for p53 dysfunction in human hepatocellular carcinomas, little is known of the...
Every year 500 000 people die worldwide due to the consequences of a hepatocellular carcinoma (HCC)....
The CDK inhibitor p21 (WAF-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G1 ...
Hereditary Tyrosinemia type 1 (HT1) is a metabolic liver disease caused by genetic defects of fumary...
Genetic mouse studies suggest that the NF-¿B pathway regulator NEMO (also known as IKK¿) controls ch...